Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)

被引：0
|
作者：
Goossens M. [1 ]
Zeegers M. [2 ]
Van Poppel H. [3 ,4 ]
Joniau S. [3 ,4 ]
Ackaert K. [5 ]
Ameye F. [6 ]
Billiet I. [7 ]
Dillen K. [8 ]
Goeman L. [9 ]
Van Bruwaene S. [3 ,4 ]
Van der Aa F. [3 ,4 ]
Vekemans K. [8 ]
Buntinx F. [1 ]
机构：
[1] KU Leuven, Leuven
[2] University Maastricht, Maastricht
[3] UZ Leuven, Leuven
[4] UZ Leuven, Leuven
[5] Sint-Elisabethziekenhuis, Turnhout
[6] AZ Maria Middelares, Gent
[7] AZ Groeninge, Kortrijk
[8] Jessa ziekenhuis, Hasselt
[9] H. Hart ziekenhuis, Roeselaere
来源：
Archives of Public Health | / 73卷 / Suppl 1期
关键词：
Selenium; Bladder Cancer; Standard Care; Transitional Cell Carcinoma; Selenium Concentration;
D O I：
10.1186/2049-3258-73-S1-P5
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [1] Designing the selenium and bladder cancer trial (SELEBLAT), a phase III randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
    Goossens, Maria E.
    Buntinx, Frank
    Joniau, Steven
    Ackaert, Koen
    Ameye, Filip
    Billiet, Ignace
    Braeckman, Johan
    Breugelmans, Alex
    Darras, Jochen
    Dilen, Kurt
    Goeman, Lieven
    Kellen, Eliane
    Tombal, Bertrand
    Van Bruwaene, Siska
    Van Cleyenbreuge, Ben
    Van der Aa, Frank
    Vekemans, Kris
    Van Poppel, Hendrik
    Zeegers, Maurice P.
    BMC UROLOGY, 2012, 12
  • [2] Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial
    Goossens, Maria E.
    Zeegers, Maurice P.
    van Poppel, Hendrik
    Joniau, Steven
    Ackaert, Koen
    Ameye, Filip
    Billiet, Ignace
    Braeckman, Johan
    Breugelmans, Alex
    Darras, Jochen
    Dilen, Kurt
    Goeman, Lieven
    Tombal, Bertrand
    Van Bruwaene, Siska
    Van Cleyenbreugel, Ben
    Van der Aa, Frank
    Vekemans, Kris
    Buntinx, Frank
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : 9 - 18
  • [3] Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
    Maria E Goossens
    Frank Buntinx
    Steven Joniau
    Koen Ackaert
    Filip Ameye
    Ignace Billiet
    Johan Braeckman
    Alex Breugelmans
    Jochen Darras
    Kurt Dilen
    Lieven Goeman
    Eliane Kellen
    Bertrand Tombal
    Siska Van Bruwaene
    Ben Van Cleyenbreuge
    Frank Van der Aa
    Kris Vekemans
    Hendrik Van Poppel
    Maurice P Zeegers
    BMC Urology, 12
  • [4] Use of selenium in chemoprevention of bladder cancer
    Brinkman, Maree
    Buntinx, Frank
    Muls, Erik
    Zeegers, Maurice P.
    LANCET ONCOLOGY, 2006, 7 (09): : 766 - 774
  • [5] Non-invasive molecular detection of bladder cancer recurrence
    Amira, N
    Mourah, S
    Rozet, F
    Teillac, P
    Fiet, J
    Aubin, P
    Cortesse, A
    Desgrandchamps, F
    Le Duc, A
    Cussenot, O
    Soliman, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 101 (03) : 293 - 297
  • [6] Prediagnostic toenail selenium and risk of bladder cancer.
    Zéegers, M
    Goldbohm, A
    Bode, P
    van den Brandt, P
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S43 - S43
  • [7] A multiplex immunoassay for the non-invasive detection of bladder cancer.
    Rosser, Charles Joel
    Shimizu, Yoshiko
    Furuya, Hideki
    Bryant-Greenwood, Peter
    Chan, Owen
    Dai, Yunfeng
    Thornquist, Mark
    Goodison, Steve
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression A Randomized Clinical Trial
    Bryan, Richard T.
    Pirrie, Sarah J.
    Abbotts, Ben
    Maycock, Shanna
    During, Vinnie
    Lewis, Carolyn
    Grant, Margaret
    Bird, Deborah
    Devall, Adam J.
    Wallace, D. Michael A.
    James, Nicholas D.
    Billingham, Lucinda J.
    Zeegers, Maurice P.
    Cheng, K. K.
    JAMA NETWORK OPEN, 2023, 6 (10) : E2337494
  • [9] Non-invasive bladder cancer
    Burger, Maximilian
    Schwaibold, Hartwig
    Goebell, Peter
    Grimm, Marc-Oliver
    ONKOLOGE, 2018, 24 (01): : 23 - 31
  • [10] Significance of uroplakin III expression in recurrence of solitary muscle non-invasive bladder cancer
    Tadin, Tomislav
    Krpina, Kristian
    Stifter, Sanja
    Babarovic, Emina
    Jonjic, Nives
    PATHOLOGY RESEARCH AND PRACTICE, 2014, 210 (05) : 279 - 284
12345